Calls Purchased on Regeneron Pharmaceuticals (REGN)

Shares of Regeneron Pharmaceuticals, Inc. REGN are higher on the session by 3.27%, currently trading at $26.85. The stock has been moving largely higher over the past four months after bouncing off of the $22.00 level and rallying above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A short while ago the December $30.00 call was purchased 1,000 times, on the offer, on open interest of 1,677 contracts. Overall call volume is now running at 2.61x the daily average with 97% of all calls traded being purchases on the offer. Regeneron Pharmaceuticals, Inc. is engaged in the research, development and commercialization of therapeutics to treat human disorders and conditions. The company's facilities are primarily located in New York.